Osiris Therapeutics Inc (NASDAQ:OSIR)

12.39
Data as of Apr 17
 -0.41 / -3.20%
Today’s Change
9.84
Today|||52-Week Range
27.40
-22.95%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$461.3M

Company Description

Osiris Therapeutics, Inc. is a stem cell company, which focuses on developing and marketing products to treat medical conditions in the inflammatory, cardiovascular, orthopedic and wound healing markets. The company operates its business through two segments: Therapeutics and Biosurgery segment. The Therapeutics segment focuses on developing biologic stem cell drug candidates from readily available and non-controversial sources. The segment, using mesenchymal stem cell technology offers two biologic drug candidates, Prochymal and Chondrogen which has anti-inflammatory properties. The Biosurgery segment works to harness the ability of cells and novel constructs to promote the body's natural healing. The segment manufactures, markets and distributes Grafix and Ovation for tissue repair. Osiris Therapeutics was founded by Peter A. Friedli and James S. Burns on December 23, 1992 and is headquartered in Columbia, MD.

Contact Information

Osiris Therapeutics, Inc.
7015 Albert Einstein Drive
Columbia Maryland 21046-1707
P:(443) 545-1800
Investor Relations:

Employees

Shareholders

Other institutional9.36%
Individual stakeholders44.79%
Mutual fund holders14.36%

Top Executives

Lode DebrabanderePresident, Chief Executive Officer, COO & Director
Philip R. JacobyChief Financial Officer, Secretary & Treasurer
Alla DanilkovitchVice President-Research & Development
Douglas JacobsteinSenior Medial Director
Frank D. CzworkaVice President & General Manager-Wound Care

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.